Search for a state or federal candidate to see the donors and industries that support them. Ballot measures allow voters to vote directly on a law or policy change. Explore the ballot measures ...

Against this backdrop, Cubist is investing $400 million this year in antibiotic R&D. Cubist extends superbug R&D to Europe | pharmaphorum Skip to main content ...

Praveen Tipirneni, MD is President and CEO of Morphic Therapeutic Inc. Previously, he was Senior Vice President of Corporate Development and Global Strategy at Cubist Pharmaceuticals, a position ...

A tech company creating computer games as therapy for children with ADHD has just recruited former execs from Google, entertainment giant DreamWorks and pharma company Cubist. Akili Interactive ...

In early 2001, it had also in-licensed European rights to Cidecin, an injectable anti-infective from Cubist Pharmaceuticals in Lexington, Massachusetts. But what Gilead really needed, management ...